Abiomed, Inc.ABMDNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank93
3Y CAGR+6.2%
5Y CAGR+31.0%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
+6.2%/yr
vs +52.9%/yr prior
5Y CAGR
+31.0%/yr
Recent deceleration
Acceleration
-46.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2022 | $249.63M | +12.9% |
| 2021 | $221.19M | -18.4% |
| 2020 | $270.91M | +30.1% |
| 2019 | $208.19M | +52.3% |
| 2018 | $136.68M | +111.3% |
| 2017 | $64.70M | +5.8% |
| 2016 | $61.17M | +60.5% |
| 2015 | $38.10M | +84.0% |
| 2014 | $20.70M | -12.1% |
| 2013 | $23.56M | - |